To read the full story, subscribe or sign in.

Proteomics Study Puts Cellular Signalling Pathways In Scrutiny

June 15, 2005

By Sharon Kingman

BioWorld

Today's news in brief

BioWorld

BioWorld briefs for Aug. 25, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Aug. 25, 2025.

Medtronic expects its Hugo robotic system set to drive future growth

BioWorld MedTech

Medtronic plc expects its Hugo robotic-assisted surgery system to be a key growth driver, especially when it receives U.S. FDA approval. Already approved for use...

Illustration of triple-negative breast cancer cells

SHCBP1 is triple-negative breast cancer driver, potential target

BioWorld Science

Triple-negative breast cancer (TNBC) accounts for a substantial proportion of all breast cancers and is the most aggressive form of the disease. Identifying...

TIPE2 is prognostic marker in colorectal cancer

BioWorld MedTech

Colorectal cancer is among the most common malignant tumor types and the second leading cause of tumor-related deaths worldwide. Tumor necrosis factor α-induced...